Year : 2022  |  Volume : 15  |  Issue : 1  |  Page : 58--60

Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications


Eyal Sagiv, Sathish Mallenahalli Chikkabyrappa, Jeffrey Conwell, Mark Lewin, Terrence Un Hoong Chun 
 Division of Pediatric Cardiology, Seattle Children's Hospital and the University of Washington School of Medicine, Seattle, WA, USA

Correspondence Address:
Dr. Eyal Sagiv
4800 Sand Point Way NE, RC.2.839, Seattle, WA 98105
USA

We report treating a term neonate with tuberous sclerosis and giant rhabdomyomas who presented with incessant supraventricular tachycardia with Everolimus. The treatment was efficient in reducing tumor size and assisted as an adjunct therapy in controlling arrhythmia and limiting preexcitation. Treatment was challenged by difficulty to achieve stable drug level and limited by neutropenia as a serious side effect.


How to cite this article:
Sagiv E, Chikkabyrappa SM, Conwell J, Lewin M, Chun TU. Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications.Ann Pediatr Card 2022;15:58-60


How to cite this URL:
Sagiv E, Chikkabyrappa SM, Conwell J, Lewin M, Chun TU. Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications. Ann Pediatr Card [serial online] 2022 [cited 2022 Aug 20 ];15:58-60
Available from: https://www.annalspc.com/article.asp?issn=0974-2069;year=2022;volume=15;issue=1;spage=58;epage=60;aulast=Sagiv;type=0